Multivariate analysis of prognostic factors in patients with nodular melanoma
Purpose Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients. Methods We studied 228 patients with NN and 396...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and clinical oncology 2021-09, Vol.147 (9), p.2759-2764 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2764 |
---|---|
container_issue | 9 |
container_start_page | 2759 |
container_title | Journal of cancer research and clinical oncology |
container_volume | 147 |
creator | Susok, L. Stücker, M. Bechara, F. G. Stockfleth, E. Gambichler, T. |
description | Purpose
Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients.
Methods
We studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann–Whitney test, Chi-square test, Kaplan–Meier curves including the log-rank test, and logistic regression model.
Results
When compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death.
Conclusions
We did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression. |
doi_str_mv | 10.1007/s00432-021-03562-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8310843</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2493455763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-83f7b9fdd67f404e15ce5964bb38d4726510eac2de9ebfa3b61719b7797114253</originalsourceid><addsrcrecordid>eNp9kUtPxCAUhYnR6Pj4Ay4MiRs3VS6P0m5MjPGVaNzomtCWzmDaMgLV-O9lnPG5cEXgfvfcczkI7QM5BkLkSSCEM5oRChlhIqcZrKEJLJ6AMbGOJgQkZIJCvoW2Q3gi6S4k3URbjOWMACsn6O5u7KJ90d7qaLAedPcWbMCuxXPvpoML0da41XV0PmA74LmO1gwx4FcbZ3hwzdhpj3vT6cH1ehdttLoLZm917qDHy4uH8-vs9v7q5vzsNqu55DErWCursm2aXLaccAOiNqLMeVWxouGS5gKI0TVtTGmqVrMqT4uUlZSlBOBUsB10utSdj1Vvmjo58rpTc2977d-U01b9rgx2pqbuRRUMSMFZEjhaCXj3PJoQVW9Dbbq0hnFjUJSXjAsh8wV6-Ad9cqNPH5UoIXiRfJcLii6p2rsQvGm_zABRi7TUMi2V0lIfaSlITQc_1_hq-YwnAWwJhFQapsZ_z_5H9h1C-aDq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554896493</pqid></control><display><type>article</type><title>Multivariate analysis of prognostic factors in patients with nodular melanoma</title><source>SpringerLink (Online service)</source><creator>Susok, L. ; Stücker, M. ; Bechara, F. G. ; Stockfleth, E. ; Gambichler, T.</creator><creatorcontrib>Susok, L. ; Stücker, M. ; Bechara, F. G. ; Stockfleth, E. ; Gambichler, T.</creatorcontrib><description>Purpose
Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients.
Methods
We studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann–Whitney test, Chi-square test, Kaplan–Meier curves including the log-rank test, and logistic regression model.
Results
When compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death.
Conclusions
We did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression.</description><identifier>ISSN: 0171-5216</identifier><identifier>EISSN: 1432-1335</identifier><identifier>DOI: 10.1007/s00432-021-03562-1</identifier><identifier>PMID: 33630139</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer Research ; Death ; Hematology ; Internal Medicine ; Medicine ; Medicine & Public Health ; Melanoma ; Multivariate analysis ; Nevus ; Oncology ; Original Article – Clinical Oncology ; Original – Clinical Oncology ; Tumors</subject><ispartof>Journal of cancer research and clinical oncology, 2021-09, Vol.147 (9), p.2759-2764</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-83f7b9fdd67f404e15ce5964bb38d4726510eac2de9ebfa3b61719b7797114253</citedby><cites>FETCH-LOGICAL-c474t-83f7b9fdd67f404e15ce5964bb38d4726510eac2de9ebfa3b61719b7797114253</cites><orcidid>0000-0001-7862-3695</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00432-021-03562-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00432-021-03562-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33630139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Susok, L.</creatorcontrib><creatorcontrib>Stücker, M.</creatorcontrib><creatorcontrib>Bechara, F. G.</creatorcontrib><creatorcontrib>Stockfleth, E.</creatorcontrib><creatorcontrib>Gambichler, T.</creatorcontrib><title>Multivariate analysis of prognostic factors in patients with nodular melanoma</title><title>Journal of cancer research and clinical oncology</title><addtitle>J Cancer Res Clin Oncol</addtitle><addtitle>J Cancer Res Clin Oncol</addtitle><description>Purpose
Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients.
Methods
We studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann–Whitney test, Chi-square test, Kaplan–Meier curves including the log-rank test, and logistic regression model.
Results
When compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death.
Conclusions
We did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression.</description><subject>Cancer Research</subject><subject>Death</subject><subject>Hematology</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Melanoma</subject><subject>Multivariate analysis</subject><subject>Nevus</subject><subject>Oncology</subject><subject>Original Article – Clinical Oncology</subject><subject>Original – Clinical Oncology</subject><subject>Tumors</subject><issn>0171-5216</issn><issn>1432-1335</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kUtPxCAUhYnR6Pj4Ay4MiRs3VS6P0m5MjPGVaNzomtCWzmDaMgLV-O9lnPG5cEXgfvfcczkI7QM5BkLkSSCEM5oRChlhIqcZrKEJLJ6AMbGOJgQkZIJCvoW2Q3gi6S4k3URbjOWMACsn6O5u7KJ90d7qaLAedPcWbMCuxXPvpoML0da41XV0PmA74LmO1gwx4FcbZ3hwzdhpj3vT6cH1ehdttLoLZm917qDHy4uH8-vs9v7q5vzsNqu55DErWCursm2aXLaccAOiNqLMeVWxouGS5gKI0TVtTGmqVrMqT4uUlZSlBOBUsB10utSdj1Vvmjo58rpTc2977d-U01b9rgx2pqbuRRUMSMFZEjhaCXj3PJoQVW9Dbbq0hnFjUJSXjAsh8wV6-Ad9cqNPH5UoIXiRfJcLii6p2rsQvGm_zABRi7TUMi2V0lIfaSlITQc_1_hq-YwnAWwJhFQapsZ_z_5H9h1C-aDq</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Susok, L.</creator><creator>Stücker, M.</creator><creator>Bechara, F. G.</creator><creator>Stockfleth, E.</creator><creator>Gambichler, T.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7862-3695</orcidid></search><sort><creationdate>20210901</creationdate><title>Multivariate analysis of prognostic factors in patients with nodular melanoma</title><author>Susok, L. ; Stücker, M. ; Bechara, F. G. ; Stockfleth, E. ; Gambichler, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-83f7b9fdd67f404e15ce5964bb38d4726510eac2de9ebfa3b61719b7797114253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer Research</topic><topic>Death</topic><topic>Hematology</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Melanoma</topic><topic>Multivariate analysis</topic><topic>Nevus</topic><topic>Oncology</topic><topic>Original Article – Clinical Oncology</topic><topic>Original – Clinical Oncology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Susok, L.</creatorcontrib><creatorcontrib>Stücker, M.</creatorcontrib><creatorcontrib>Bechara, F. G.</creatorcontrib><creatorcontrib>Stockfleth, E.</creatorcontrib><creatorcontrib>Gambichler, T.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cancer research and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Susok, L.</au><au>Stücker, M.</au><au>Bechara, F. G.</au><au>Stockfleth, E.</au><au>Gambichler, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multivariate analysis of prognostic factors in patients with nodular melanoma</atitle><jtitle>Journal of cancer research and clinical oncology</jtitle><stitle>J Cancer Res Clin Oncol</stitle><addtitle>J Cancer Res Clin Oncol</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>147</volume><issue>9</issue><spage>2759</spage><epage>2764</epage><pages>2759-2764</pages><issn>0171-5216</issn><eissn>1432-1335</eissn><abstract>Purpose
Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients.
Methods
We studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann–Whitney test, Chi-square test, Kaplan–Meier curves including the log-rank test, and logistic regression model.
Results
When compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death.
Conclusions
We did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33630139</pmid><doi>10.1007/s00432-021-03562-1</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7862-3695</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0171-5216 |
ispartof | Journal of cancer research and clinical oncology, 2021-09, Vol.147 (9), p.2759-2764 |
issn | 0171-5216 1432-1335 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8310843 |
source | SpringerLink (Online service) |
subjects | Cancer Research Death Hematology Internal Medicine Medicine Medicine & Public Health Melanoma Multivariate analysis Nevus Oncology Original Article – Clinical Oncology Original – Clinical Oncology Tumors |
title | Multivariate analysis of prognostic factors in patients with nodular melanoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A09%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multivariate%20analysis%20of%20prognostic%20factors%20in%20patients%20with%20nodular%20melanoma&rft.jtitle=Journal%20of%20cancer%20research%20and%20clinical%20oncology&rft.au=Susok,%20L.&rft.date=2021-09-01&rft.volume=147&rft.issue=9&rft.spage=2759&rft.epage=2764&rft.pages=2759-2764&rft.issn=0171-5216&rft.eissn=1432-1335&rft_id=info:doi/10.1007/s00432-021-03562-1&rft_dat=%3Cproquest_pubme%3E2493455763%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2554896493&rft_id=info:pmid/33630139&rfr_iscdi=true |